Logo image of ICOS.MI

INTERCOS SPA (ICOS.MI) Stock Fundamental Analysis

Europe - BIT:ICOS - IT0005455875 - Common Stock

12.34 EUR
+0.16 (+1.31%)
Last: 9/24/2025, 4:55:46 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ICOS. ICOS was compared to 13 industry peers in the Personal Care Products industry. ICOS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, ICOS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ICOS was profitable.
In the past year ICOS had a positive cash flow from operations.
In the past 5 years ICOS has always been profitable.
Each year in the past 5 years ICOS had a positive operating cash flow.
ICOS.MI Yearly Net Income VS EBIT VS OCF VS FCFICOS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

ICOS's Return On Assets of 4.71% is on the low side compared to the rest of the industry. ICOS is outperformed by 61.54% of its industry peers.
Looking at the Return On Equity, with a value of 10.16%, ICOS is doing worse than 61.54% of the companies in the same industry.
ICOS's Return On Invested Capital of 9.59% is in line compared to the rest of the industry. ICOS outperforms 46.15% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ICOS is below the industry average of 12.52%.
The 3 year average ROIC (9.32%) for ICOS is below the current ROIC(9.59%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.71%
ROE 10.16%
ROIC 9.59%
ROA(3y)4.84%
ROA(5y)4.37%
ROE(3y)10.88%
ROE(5y)10.92%
ROIC(3y)9.32%
ROIC(5y)8.1%
ICOS.MI Yearly ROA, ROE, ROICICOS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 4.34%, ICOS is doing worse than 61.54% of the companies in the same industry.
In the last couple of years the Profit Margin of ICOS has declined.
Looking at the Operating Margin, with a value of 9.31%, ICOS is doing worse than 61.54% of the companies in the same industry.
ICOS's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 19.84%, ICOS is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
ICOS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.31%
PM (TTM) 4.34%
GM 19.84%
OM growth 3Y-0.98%
OM growth 5Y-5.21%
PM growth 3Y4.42%
PM growth 5Y-5.47%
GM growth 3Y-3.29%
GM growth 5Y-3.96%
ICOS.MI Yearly Profit, Operating, Gross MarginsICOS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ICOS is creating some value.
Compared to 1 year ago, ICOS has about the same amount of shares outstanding.
The number of shares outstanding for ICOS has been increased compared to 5 years ago.
Compared to 1 year ago, ICOS has a worse debt to assets ratio.
ICOS.MI Yearly Shares OutstandingICOS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ICOS.MI Yearly Total Debt VS Total AssetsICOS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

ICOS has an Altman-Z score of 3.46. This indicates that ICOS is financially healthy and has little risk of bankruptcy at the moment.
ICOS's Altman-Z score of 3.46 is in line compared to the rest of the industry. ICOS outperforms 53.85% of its industry peers.
ICOS has a debt to FCF ratio of 16.66. This is a negative value and a sign of low solvency as ICOS would need 16.66 years to pay back of all of its debts.
ICOS has a Debt to FCF ratio of 16.66. This is amonst the worse of the industry: ICOS underperforms 92.31% of its industry peers.
A Debt/Equity ratio of 0.52 indicates that ICOS is somewhat dependend on debt financing.
ICOS has a Debt to Equity ratio (0.52) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 16.66
Altman-Z 3.46
ROIC/WACC1.41
WACC6.8%
ICOS.MI Yearly LT Debt VS Equity VS FCFICOS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.67 indicates that ICOS should not have too much problems paying its short term obligations.
ICOS has a better Current ratio (1.67) than 76.92% of its industry peers.
ICOS has a Quick Ratio of 1.03. This is a normal value and indicates that ICOS is financially healthy and should not expect problems in meeting its short term obligations.
ICOS has a better Quick ratio (1.03) than 69.23% of its industry peers.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.03
ICOS.MI Yearly Current Assets VS Current LiabilitesICOS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

ICOS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.80%.
Measured over the past 5 years, ICOS shows a small growth in Earnings Per Share. The EPS has been growing by 1.57% on average per year.
The Revenue has grown by 9.02% in the past year. This is quite good.
ICOS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.36% yearly.
EPS 1Y (TTM)4.8%
EPS 3Y20.17%
EPS 5Y1.57%
EPS Q2Q%-6.97%
Revenue 1Y (TTM)9.02%
Revenue growth 3Y16.49%
Revenue growth 5Y8.36%
Sales Q2Q%5%

3.2 Future

Based on estimates for the next years, ICOS will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.72% on average per year.
The Revenue is expected to grow by 1.81% on average over the next years.
EPS Next Y4.9%
EPS Next 2Y11.02%
EPS Next 3Y11.72%
EPS Next 5YN/A
Revenue Next Year2.69%
Revenue Next 2Y4.22%
Revenue Next 3Y4.75%
Revenue Next 5Y1.81%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ICOS.MI Yearly Revenue VS EstimatesICOS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
ICOS.MI Yearly EPS VS EstimatesICOS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 25.18, which means the current valuation is very expensive for ICOS.
Compared to the rest of the industry, the Price/Earnings ratio of ICOS is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.41, ICOS is valued at the same level.
The Price/Forward Earnings ratio is 15.81, which indicates a correct valuation of ICOS.
Based on the Price/Forward Earnings ratio, ICOS is valued a bit cheaper than the industry average as 76.92% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.87, ICOS is valued a bit cheaper.
Industry RankSector Rank
PE 25.18
Fwd PE 15.81
ICOS.MI Price Earnings VS Forward Price EarningsICOS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ICOS is valued a bit cheaper than 69.23% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ICOS indicates a rather expensive valuation: ICOS more expensive than 84.62% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 75.92
EV/EBITDA 8.32
ICOS.MI Per share dataICOS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ICOS does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)5.13
PEG (5Y)16.03
EPS Next 2Y11.02%
EPS Next 3Y11.72%

2

5. Dividend

5.1 Amount

ICOS has a Yearly Dividend Yield of 1.59%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.63, ICOS is paying slightly less dividend.
ICOS's Dividend Yield is slightly below the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.59%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

38.09% of the earnings are spent on dividend by ICOS. This is a low number and sustainable payout ratio.
DP38.09%
EPS Next 2Y11.02%
EPS Next 3Y11.72%
ICOS.MI Yearly Income VS Free CF VS DividendICOS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ICOS.MI Dividend Payout.ICOS.MI Dividend Payout, showing the Payout Ratio.ICOS.MI Dividend Payout.PayoutRetained Earnings

INTERCOS SPA

BIT:ICOS (9/24/2025, 4:55:46 PM)

12.34

+0.16 (+1.31%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-04 2025-08-04
Earnings (Next)11-06 2025-11-06
Inst Owners38.09%
Inst Owner ChangeN/A
Ins Owners32.17%
Ins Owner ChangeN/A
Market Cap1.19B
Analysts86.67
Price Target17.39 (40.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.59%
Yearly Dividend0.19
Dividend Growth(5Y)N/A
DP38.09%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.84%
PT rev (3m)-0.78%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-8.48%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.36%
Revenue NY rev (3m)-3.57%
Valuation
Industry RankSector Rank
PE 25.18
Fwd PE 15.81
P/S 1.09
P/FCF 75.92
P/OCF 13.29
P/B 2.55
P/tB 4.47
EV/EBITDA 8.32
EPS(TTM)0.49
EY3.97%
EPS(NY)0.78
Fwd EY6.33%
FCF(TTM)0.16
FCFY1.32%
OCF(TTM)0.93
OCFY7.52%
SpS11.31
BVpS4.83
TBVpS2.76
PEG (NY)5.13
PEG (5Y)16.03
Profitability
Industry RankSector Rank
ROA 4.71%
ROE 10.16%
ROCE 14.65%
ROIC 9.59%
ROICexc 11.59%
ROICexgc 17.27%
OM 9.31%
PM (TTM) 4.34%
GM 19.84%
FCFM 1.44%
ROA(3y)4.84%
ROA(5y)4.37%
ROE(3y)10.88%
ROE(5y)10.92%
ROIC(3y)9.32%
ROIC(5y)8.1%
ROICexc(3y)12.89%
ROICexc(5y)11.65%
ROICexgc(3y)22.3%
ROICexgc(5y)20.57%
ROCE(3y)14.06%
ROCE(5y)12.06%
ROICexcg growth 3Y0.58%
ROICexcg growth 5Y-13.66%
ROICexc growth 3Y4.35%
ROICexc growth 5Y-9.88%
OM growth 3Y-0.98%
OM growth 5Y-5.21%
PM growth 3Y4.42%
PM growth 5Y-5.47%
GM growth 3Y-3.29%
GM growth 5Y-3.96%
F-Score7
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 16.66
Debt/EBITDA 1.6
Cap/Depr 144.42%
Cap/Sales 6.77%
Interest Coverage 11.2
Cash Conversion 58.65%
Profit Quality 33.11%
Current Ratio 1.67
Quick Ratio 1.03
Altman-Z 3.46
F-Score7
WACC6.8%
ROIC/WACC1.41
Cap/Depr(3y)119.92%
Cap/Depr(5y)113.2%
Cap/Sales(3y)5.7%
Cap/Sales(5y)5.95%
Profit Quality(3y)77.95%
Profit Quality(5y)89.83%
High Growth Momentum
Growth
EPS 1Y (TTM)4.8%
EPS 3Y20.17%
EPS 5Y1.57%
EPS Q2Q%-6.97%
EPS Next Y4.9%
EPS Next 2Y11.02%
EPS Next 3Y11.72%
EPS Next 5YN/A
Revenue 1Y (TTM)9.02%
Revenue growth 3Y16.49%
Revenue growth 5Y8.36%
Sales Q2Q%5%
Revenue Next Year2.69%
Revenue Next 2Y4.22%
Revenue Next 3Y4.75%
Revenue Next 5Y1.81%
EBIT growth 1Y16.33%
EBIT growth 3Y15.34%
EBIT growth 5Y2.71%
EBIT Next Year74.29%
EBIT Next 3Y27.67%
EBIT Next 5YN/A
FCF growth 1Y-69.82%
FCF growth 3Y14.23%
FCF growth 5Y-3.11%
OCF growth 1Y-14.11%
OCF growth 3Y17%
OCF growth 5Y3.39%